VF
VYNE icon

Virtu Financial’s VYNE Therapeutics VYNE Stock Holding History

Virtu Financial’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,327
Closed -$15K – 2361
2025
Q4 		$15K Buy
+25,327
New +$10.2K ﹤0.01% 1473
2025
Q2 		– Sell
-19,574
Closed -$31K – 2076
2025
Q1 		$31K Buy
+19,574
New +$48.2K ﹤0.01% 1069
2024
Q2 		– Sell
-16,199
Closed -$50K – 1931
2024
Q1 		$50K Buy
+16,199
New +$34.9K ﹤0.01% 1029
2022
Q4 		– Sell
-3,415
Closed -$14K – 2183
2022
Q3 		$14K Sell
3,415
-187
-5% -$1.2K ﹤0.01% 1477
2022
Q2 		$25K Buy
3,602
+2,235
+163% +$18.7K ﹤0.01% 1289
2022
Q1 		$16K Sell
1,367
-8,371
-86% -$99.5K ﹤0.01% 1329
2021
Q4 		$179K Buy
9,738
+3,720
+62% +$79.8K 0.02% 876
2021
Q3 		$151K Buy
+6,018
New +$233K 0.01% 1007
2021
Q2 		– Sell
-755
Closed -$93K – 2124
2021
Q1 		$93K Sell
755
-166
-18% -$24.1K 0.01% 1338
2020
Q4 		$105K Sell
921
-849
-48% -$107K 0.01% 1042
2020
Q3 		$212K Buy
+1,770
New +$207K 0.04% 578
2019
Q4 		$59K Buy
+176
New +$58.7K 0.01% 1182
2018
Q4 		– Sell
-178
Closed -$126K – 2028
2018
Q3 		$126K Buy
+178
New +$110K 0.01% 1157

Other funds holding VYNE

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Virtu Financial's VYNE Position: Q1 2026 in Review

Virtu Financial sold out of VYNE Therapeutics (VYNE) in Q1 2026, closing a stake of 25,327 shares — an estimated $15K sold.

Virtu Financial first reported a position in VYNE in Q3 2018 and held it in 13 quarters. The position peaked at $212K in Q3 2020. 45 funds tracked by Wall St. Rank hold VYNE as of Q1 2026.

  • Virtu Financial reported no remaining VYNE Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 25,327 VYNE Therapeutics shares in Q1 2026, an estimated $15K.
  • Virtu Financial first reported a position in VYNE Therapeutics in Q3 2018 and held it in 13 quarters.
  • Virtu Financial's VYNE Therapeutics position peaked at $212K in Q3 2020.
  • 45 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.